MDNC (Medinotec) Ending Cash Position: $2.52 Mil (As of May. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MDNC Medinotec Inc MDNC
24 GF Score
Price $5.00
! 1 Warning Sign
View Full Analysis

What is Medinotec Ending Cash Position?

Medinotec MDNC 24 Ending Cash Position is $2.52 Mil as of May. 2026. GuruFocus rates MDNC with a GF Score™ of 24/100. The stock has 1 warning sign investors should review.

Medinotec's Ending Cash Position for the quarter that ended in May. 2026 was $2.52 Mil.

Medinotec's quarterly Ending Cash Position declined from Nov. 2025 ($2.86 Mil) to Feb. 2026 ($2.76 Mil) and declined from Feb. 2026 ($2.76 Mil) to May. 2026 ($2.52 Mil).

Medinotec's annual Ending Cash Position declined from Feb. 2024 ($2.81 Mil) to Feb. 2025 ($2.77 Mil) and declined from Feb. 2025 ($2.77 Mil) to Feb. 2026 ($2.76 Mil).

Medinotec Ending Cash Position Related Terms

Medinotec Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Medinotec's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medinotec Ending Cash Position Chart

Medinotec Annual Data
Trend Feb22 Feb23 Feb24 Feb25 Feb26
Ending Cash Position
0.00 2.83 2.81 2.77 2.76

Medinotec Quarterly Data
Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26 May26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.95 2.25 2.86 2.76 2.52
MDNC
24GF Score
Medinotec Inc MDNC
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medinotec Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Medinotec's Ending Cash Position for the fiscal year that ended in Feb. 2026 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=2.769+-0.012
=2.76

Medinotec's Ending Cash Position for the quarter that ended in May. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=2.756+-0.238
=2.52

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $2.52 Mil mean?
Medinotec (MDNC) has a Ending Cash Position of $2.52 Mil as of May. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Medinotec and its competitors.
Is Medinotec's Ending Cash Position too high?
Medinotec's current Ending Cash Position is $2.52 Mil. Overall, Medinotec has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Medinotec's Ending Cash Position compare to NVNO and APYX?
Medinotec's Ending Cash Position of $2.52 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Medical Devices & Instruments company?
A good Ending Cash Position depends on the Medical Devices & Instruments industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Medinotec and its competitors. Medinotec's current Ending Cash Position is $2.52 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medinotec stock overvalued right now?
Medinotec (MDNC) has a current Ending Cash Position of $2.52 Mil. The current Ending Cash Position is $2.52 Mil. Medinotec's overall GF Score™ is 24/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Medinotec (MDNC), the current Ending Cash Position is $2.52 Mil as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medinotec Business Description

Address Stand 299 Avant Garde Avenue, 10 New Market Street, Northlands Deco Park, North Riding, Johannesburg, GT, ZAF, 2169
Medinotec Inc is a medical device manufacturing and distribution company engaged in tracheal non-occlusive airway dilation technology and medical device design. It generates revenue from two sources: internally designed and manufactured medical devices and distribution of third-party medical products under exclusive or non-exclusive agreements in defined territories. Its products include the Trachealator, the Outflo Aortic Valve Dilation Balloon Catheter, and the Cape Cross family of PTCA balloon catheters. It also distributes a range of cardiology and renal dialysis products on behalf of multinational manufacturers, mainly in South Africa. Its segments are Inside the United States and Outside the United States, with Outside the United States generating maximum revenue.
24GF Score

Get the complete analysis for MDNC

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.00
Price